TL;DR
Before we dive into the full story, here's a quick TL;DR answering the five questions investors ask most often:
1
Why now & what problem are you solving?
+
The $32.7B lactation/breastfeeding market is fragmented with no clear leader (largest player <15% share). Most of the market relies on manual processes with minimal technology integration.
The Problem: 40% of mothers quit breastfeeding within 3 months due to "insufficient supply" anxiety—they have no objective data about milk intake.
Our Approach: Launch as consumer wellness product first (BMMPP - Best Minimal Mother Pay Product). Fast market entry, no FDA delays. Prove product-market fit with paying mothers, then scale to hospitals and regulatory approval.
Why Now: Parents demand quantified solutions. Technology is ready (sensor commoditization, AI maturity). Consumer-first path de-risks the business before expensive hospital/FDA investment.
2
How big is the market?
+
Total Market: $32.7B/year across developed countries (OECD + high-income nations), growing 6-8% CAGR overall.
MonBe's Addressable Market: $6.6B (after excluding entrenched hardware players, pure labor services, and existing software solutions).
Realistic Year 5 Revenue Target: $150M-$200M ARR (2.3-3.0% market capture) with clear path to $1.0B-$1.2B valuation.
3
What is your competitive advantage?
+
The Only Integrated Ecosystem: MonBe is the ONLY platform serving consumers (mothers), professionals (consultants), institutions (hospitals), and payers (insurance) simultaneously.
Network Effects Moat: Consumer data → Professional insights → Hospital adoption creates a virtuous cycle competitors can't replicate without entering all three markets at once.
Technical Edge: Multi-sensor fusion (5 sensors vs. competitors' single sensor), NFC transfer, provisional patent filed Aug 2025, and favorable patent landscape.
4
Who is the team & how do you scale?
+
Founder: Eitan Halfon, Ex-SolarEdge (NASDAQ: SEDG). BSc Electrical & Computer Engineering, MSc Global Financial Economics. Deep expertise in hardware systems that scale.
Go-to-Market Strategy:
- Phase 1 (Pre-Seed): Consumer Launch – Build BMMPP (Best Minimal Mother Pay Product). Launch DTC in USA with 5K-10K paying mothers. Prove product-market fit and gather clinical data. No FDA or hospital work yet.
- Phase 2 (Series A): FDA Clearance + Hospital Sales – Secure FDA 510(k) approval, launch B2B hospital sales in USA with RPM billing integration.
- Phase 3 (Series B): Nordic + Germany Expansion – Enter Nordic countries (Sweden, Norway, Denmark, Finland) and Germany with both consumer and hospital channels.
- Phase 4 (Series C+): EU Expansion – Scale to remaining European Union markets leveraging established distribution and regulatory approvals.
- Exit: Strategic acquisition by Hologic, Philips Healthcare, Medtronic, or IPO. Target valuation: $1.0B-$1.2B.
5
How do you make money?
+
Dual Revenue Streams: Consumer (B2C) + Professional (B2B)
Consumer (B2C) – MonBe Core + Patches + App
Core Device
$100-200
One-time
Patches
$180-450
$20-50/mo × 9mo
App Premium
$45-135
$5-15/mo × 9mo
Customer LTV: ~$600 (avg 9 months per baby)
Target customers: 35K-80K (10-25% of tech-forward mothers)
Target: $20M-$50M/year (15-25% of revenue)
Professional (B2B) – MonBe Clinic Software
Solo Consultants: $3.5K-5K/year | Small Hospitals: $25K-40K/year | Large Hospitals: $150K-250K/year
Target customers: 500-1,000 hospitals + 2,000-5,000 consultants
Target: $130M-$150M/year (75-85% of revenue)
Year 5 Target: $150M-$200M ARR | LTV:CAC >8:1 | 70%+ Gross Margins (B2B SaaS-heavy)
Understanding Our Market Opportunity
The lactation market ($32.7B) is massive but fragmented. Not all of it is addressable by technology. Here's how we think about market sizing:
$32.7B
Total Market
All current spending on lactation services across developed countries
$6.6B
Addressable Market
After removing: entrenched hardware (40%), pure labor (30%), already-served segments (10%)
$150-200M
Year 5 Revenue
2.3-3.0% of addressable market
Why $6.6B, not $32.7B?
- Entrenched Hardware Players (40%): Medela, Spectra, traditional pumps control $13.1B through established distribution
- Pure Labor Services (30%): Consultant salaries, hospital staff time ($9.81B) won't be fully displaced by technology
- Already-Served Segments (10%): Basic apps, hospital EMR modules already capture $3.27B
- MonBe's Addressable: $6.6B — Segments underserved by integrated technology (consumer + professional + hospital)
The "Black Box" Problem
Every year, 140 million babies are born. 90% of mothers start breastfeeding. Within 3 months, 40% quit—not because they want to, but because they have no objective data.
The question "Is my baby eating enough?" has no answer. Mothers are told to trust their instincts, count diapers, and watch the clock. Meanwhile, hospitals discharge newborns without any baseline feeding data. The entire system runs on guesswork.
The Cost of Guessing:
-
$2.31B wasted on accessories that don't solve the core problem.
-
68% of medical records contain flawed feeding data.
-
Maternal Anxiety is the #1 driver of formula supplementation.
BMMPP
Best Minimal Mother Pay Product
Our pre-seed strategy: Build the simplest version of MonBe that mothers will actually pay for. No bells and whistles. Just core value—objective feeding data that answers "Is my baby eating enough?"
What's included in BMMPP:
- Core reusable sensor device ($100-200)
- Disposable sensor patches ($20-50/month)
- Mobile app with feeding insights
- Basic AI analysis of swallow patterns
What's NOT included (comes later): FDA approval, hospital integrations, EMR connectivity, RPM billing. We prove consumer demand first, then scale to regulated markets.
Complexity, Abstracted.
We took defense-grade bioimpedance sensors and hid them in a sticker.
Step 1: Apply
Passive sensor patch. No wires. No cameras. No disruption to bonding.
Step 2: Feed
We track swallowing patterns, not just time. Real physiological data.
Step 3: Sync
NFC transfer to phone. Zero radiation near baby during feeding.
The "Stripe" of Nutrition Data
Investors often mistake us for a hardware company. Hardware is just the API key.
By solving the user interface problem (a passive sticker), we unlock the Milk Graph—the world's first longitudinal dataset connecting maternal physiology, milk intake, and infant development.
$600
Consumer LTV (9 months)
$500K+
Hospital LTV (6+ years)
8:1
LTV:CAC Ratio
The B2B Engine: Hospital Sales
Investors often ask: "Where does the real revenue come from?" Answer: Hospitals. Here's how we scale B2B.
Why Hospitals First
- ✓ High ACV: $85K-250K/year (vs. $270 consumer)
- ✓ Multi-Year Contracts: 5+ year retention
- ✓ Revenue Efficiency: 1 hospital = 500+ mothers
- ✓ Expansion Revenue: 120%+ NRR (additional use cases)
- ✓ Network Effect: Hospital adoption validates product for consultants/consumers
Hospital ROI (Why They'll Buy)
- 💰 Readmission Prevention: $50K-500K saved per prevented NICU admission
- 💰 RPM Billing: $112K-216K NEW annual insurance revenue per 200-dyad hospital
- 💰 Staff Efficiency: Reduce manual follow-up calls by 60%
- 💰 Compliance: Auto-documentation for Baby-Friendly accreditation
- 💰 Payback Period: 4-8 months (ROI is immediately clear)
Hospital Pricing by Size
Small
100-200 births/mo
$25K-40K
/year
Medium
200-500 births/mo
$60K-100K
/year
Large
500+ births/mo
$150K-250K
/year
Hospital Go-to-Market (By Funding Stage)
Pre-Seed / Series A
- ✓ 3-5 hospital pilots (unpaid, data-gathering)
- ✓ Target: Baby-Friendly designated hospitals (mandate = adoption)
- ✓ Focus: Small hospitals (faster adoption, less IT friction)
- ✓ Metric: 90%+ pilot satisfaction, 3+ letters of intent for Series A
Series A / Series B
- ✓ 50-100 paying hospital customers
- ✓ RPM billing integration (insurance reimbursement)
- ✓ Hire VP Sales (healthcare B2B expert)
- ✓ Target: $60M+ of $150M Year 5 revenue from hospitals
⚡ The RPM Billing Lever: 2-3x Revenue Multiplier
This is the game-changer. Remote Patient Monitoring (RPM) isn't new, but applying it to lactation is. Here's why hospitals will self-fund MonBe through insurance reimbursement:
Medicare/Insurance Reimbursement
- CPT 99457: $47.87/month per patient monitored
- CPT 99454: $43.02/month per patient (additional)
- Total: $90-180/month per monitored dyad
Hospital Math (Typical Medium Hospital)
- Monitored Dyads/Month: 200 (typical med. hospital)
- Revenue Generated: $18K-36K/month
- Annual Revenue: $216K-432K/year
- Minus MonBe Cost: -$80K/year
- Net Profit: $136K-352K/year
The Insight: Hospitals don't pay for MonBe. Insurance pays for MonBe through RPM billing. This changes hospital acquisition calculus from "cost saving" to "revenue generation." Payback period: 2-3 months.
Why Competitors Can't Replicate This:
Requires three things simultaneously: (1) FDA clearance for medical device, (2) Deep hospital integration (not just software), (3) Insurance credibility. No other startup has all three. We'll be 18-24 months ahead.
Unit Economics
-
Hardware Kit
$150 - $250
-
Recurring Patches
$30 - $50 / mo
-
Software Subscription
$5 - $15 / mo
-
CAC (Customer Acquisition)
$50 - $75
-
Gross Margin Target
65%+
Why Now?
1. Consumer-First Validation
Launch as consumer wellness product first (fast, no FDA delays). Use real-world data and traction to accelerate hospital/FDA path later.
2. The "Quantified Baby"
Millennial parents track everything. The "black box" of breastfeeding is the last blind spot. Parents will pay for clarity.
3. Technology is Ready
Sensor commoditization + favorable patent landscape + AI maturity. Foundational IP has expired. We filed provisional patent Aug 2025.
Financial Projections: Year 1-5
We model two scenarios: Conservative (consumer-focused, slower hospital adoption) and Aggressive (balanced growth + RPM billing). Here's the path to $150M-$200M ARR:
| Metric |
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
| Consumer Users |
5K |
30K |
80K |
120K |
150K |
| Consumer ARR |
$1.4M |
$8.1M |
$21.6M |
$32.4M |
$40.5M |
| Hospital Customers |
5-10 |
50-75 |
150-200 |
300-350 |
500-600 |
| Hospital ARR |
$0.6M |
$4.5M |
$18M |
$37.5M |
$80M |
| TOTAL ARR |
$2M |
$12.6M |
$39.6M |
$69.9M |
$120.5M |
| Gross Margin |
60% |
65% |
68% |
70% |
72% |
| Series Funding |
Series A $3-5M |
Series B $12-15M |
Series C $25-35M |
Series D $40-60M |
Exit $1.0B-$1.2B |
Conservative Case: If hospital adoption is slower (200 hospitals by Year 5), Year 5 ARR is ~$40-60M (lower growth, lower exit). Aggressive Case: With RPM billing + strong hospital penetration (500+ hospitals), Year 5 ARR is $120M+ (path to $1.5B+ valuation). Our target: $150M-$200M by Year 5 (middle-to-aggressive scenario).
Market Opportunity
$32.7B
Total Market (Lactation Services)
$6.6B
Addressable Market (Tech-Enabled)
$150-200M
Year 5 Revenue Target
2.3-3.0%
Market Capture (Year 5)
Market Breakdown by Segment
Hospital Services
$11.8B (36%) — 10,700 hospitals in USA
Primary Care Clinics
$10.3B (31%) — 70,000+ clinics
Private Consultants
$4.95B (15%) — 54,500 IBCLCs
Hardware & Consumer
$3.0B (9%) — Consumer products
Key Insight: The lactation market is fragmented (no player >15% share) and growing 6-8% CAGR. MonBe's integrated platform (consumer + professional + hospital) captures value across the entire ecosystem. B2B hospital sales drive 75-85% of revenue with high margins and multi-year contracts.
The Architect.
Eitan Halfon | Electrical Engineer & Economist
"I don't believe in 'hope' as a strategy. I believe in physics and economics—and building with love."
Ex-SolarEdge (NASDAQ: SEDG). I spent my career building complex hardware systems that scale. I'm not here to build a gadget. I'm here to build the standard of baby care.
Background: BSc in Electrical & Computer Engineering, MSc in Global Financial Economics. Deep expertise in analog/digital systems, embedded development, and multidisciplinary product development.
The Ask: $600K Pre-Seed
Build BMMPP (Best Minimal Mother Pay Product) and launch consumer pilot with 5K-10K paying mothers. Prove product-market fit before scaling to hospitals and FDA approval.
Current Traction
We're in pre-seed validation mode. Here's what we've de-risked:
✓ Product Validation
- Provisional patent filed (August 2025)
- Multi-sensor prototype complete
- Alpha testing with 20+ mothers
- 99%+ sensor reliability achieved
- NFC transfer mechanism validated
✓ Market Validation
- 500+ interested mothers (waitlist)
- 3-5 hospital pilot LOIs in progress
- Clinical advisors engaged
- Pediatrician endorsement in progress
- Survey: 78% of mothers want supply tracking data
Pre-Seed Milestones (Next 12 Months)
Months 1-6
- ✓ Finalize consumer BMMPP
- ✓ Launch beta: 500 mothers
- ✓ Validate product-market fit
Months 7-12
- ✓ Scale to 5K-10K consumers
- ✓ Secure hospital pilot partnerships
- ✓ Plan Series A raise
Series A Entry Criteria: 10K+ paying consumers, 90%+ retention, 3-5 hospital pilot partnerships, clear path to RPM billing integration.
Use of Funds ($600K Pre-Seed)
Goal: Build BMMPP (Best Minimal Mother Pay Product) + Launch Consumer Pilot with 5K-10K paying mothers
Expected runway: 18 months | Burn rate: ~$35K/month | Series A entry: Month 15-18
45%
Hardware & Software
$270K for core product development
- ✓ Complete BMMPP hardware design & manufacturing
- ✓ Disposable patch sourcing & tooling
- ✓ iOS + Android mobile app development
- ✓ AI algorithm development (swallow detection)
- ✓ Security/encryption/HIPAA compliance
- ✓ Hire: 2 firmware engineers (months 1-6)
30%
Consumer Launch & Pilot
$180K for go-to-market & validation
- ✓ DTC marketing (Facebook, Instagram, TikTok)
- ✓ Customer acquisition: 500→5K→10K mothers
- ✓ Beta testing & customer support
- ✓ Clinical data collection & analysis
- ✓ Hospital pilot outreach & coordination
- ✓ Hire: Growth/marketing lead + Customer success
25%
Team & Operations
$150K for team building & overhead
- ✓ Salaries: Founder + 4 initial hires (18 months)
- ✓ Office/lab space (seed-stage lean setup)
- ✓ Legal/IP/regulatory consulting (FDA pathway planning)
- ✓ Insurance, accounting, operational overhead
18-Month Timeline
Months 1-6
Product finalization
Beta: 500 moms
Months 7-12
Scale: 5K-10K consumers
Hospital pilots
Months 13-18
Series A readiness
Hospital partnerships
Series A Entry Criteria (Month 15-18)
- ✓ 10K+ paying users
- ✓ 90%+ monthly retention
- ✓ $3M+ ARR (consumer)
- ✓ 65%+ gross margins
- ✓ 3-5 hospital pilots active
- ✓ Clinical validation partnership signed
- ✓ MVP hospital software complete
- ✓ Clear path to FDA + RPM billing